KYUNG NAM PHARM.CO.,LTD. announces capital increase
경남제약
053950
Signal Score
Historical Avg Return (5d)
+0.33%
Data Coverage
100%n=2377
Risk-adjusted indicator based on 2377 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Discount Rate: 10%
- • Lock-up Period: 1 year
AI Analysis Summary
KYUNG NAM PHARM.CO.,LTD. has decided on a paid-in capital increase via third-party allocation. The new share issuance price will be determined by applying a 10% discount to the reference stock price, calculated based on weighted average prices over 1 month, 1 week, and the most recent day. The newly issued shares will be subject to a 1-year lock-up period from the deposit date with the Korea Securities Depository. The specific number of shares, issuance price, and funding purpose are not yet disclosed, limiting a full assessment of dilution and financial impact. The overall impact is currently neutral, pending further details.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.